These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36830214)

  • 21. Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant
    Song X; Han M
    Front Cell Infect Microbiol; 2022; 12():874401. PubMed ID: 35873144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
    Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M
    Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamic Effects of Sulbactam/Meropenem/Polymyxin-B Combination Against Extremely Drug Resistant
    Menegucci TC; Fedrigo NH; Lodi FG; Albiero J; Nishiyama SAB; Mazucheli J; Carrara-Marroni FE; Voelkner NMF; Gong H; Sy SKB; Tognim MCB
    Microb Drug Resist; 2019 Nov; 25(9):1266-1274. PubMed ID: 31216222
    [No Abstract]   [Full Text] [Related]  

  • 25. Ampicillin-Sulbactam for Carbapenem-Susceptible
    Shoulders BR; Santevecchi BA; Venugopalan V; Alexander KM
    Surg Infect (Larchmt); 2024 Jul; ():. PubMed ID: 38958001
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W; Munsrichoom A; Srisarang S; Treeratweeraphong V
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ampicillin/sulbactam in elderly patients with community-acquired pneumonia.
    Majcher-Peszynska J; Loebermann M; Klammt S; Frimmel S; Mundkowski RG; Welte T; Reisinger EC; Drewelow B;
    Infection; 2014 Feb; 42(1):79-87. PubMed ID: 23904004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and pharmacodynamic analysis of cefoperazone/sulbactam for the treatment of pediatric sepsis by Monte Carlo simulation.
    Ye L; Cheng L; Kong L; Zhao X; Xie G; He J; Liu H; Deng Y; Wu X; Wang T; Yang X
    Anal Methods; 2022 Mar; 14(11):1148-1154. PubMed ID: 35225994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN).
    Lodise TP; Van Wart S; Sund ZM; Bressler AM; Khan A; Makley AT; Hamad Y; Salata RA; Silveira FP; Sims MD; Kabchi BA; Saad MA; Brown C; Oler RE; Fowler V; Wunderink RG
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33168615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of continuous ampicillin/sulbactam infusion in critically ill patients.
    Passon SG; Schmidt AR; Wittmann M; Velten M; Baehner T
    Life Sci; 2023 May; 320():121567. PubMed ID: 36907327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model-Informed Drug Development of New Cefoperazone Sodium and Sulbactam Sodium Combination (3:1): Pharmacokinetic/Pharmacodynamic Analysis and Antibacterial Efficacy Against Enterobacteriaceae.
    Ji XW; Zhu X; Li Y; Xue F; Kuan IHS; He QF; Meng XR; Xiang XQ; Cui YM; Zheng B
    Front Pharmacol; 2022; 13():856792. PubMed ID: 35924047
    [No Abstract]   [Full Text] [Related]  

  • 32. Dosing Optimization of Ampicillin-Sulbactam Based on Cystatin C in Elderly Patients with Pneumonia.
    Matsubara K; Matsumoto K; Yokoyama Y; Watanabe E; Enoki Y; Shigemi A; Ikawa K; Terazono H; Morikawa N; Ohshige T; Takeda Y
    Biol Pharm Bull; 2021; 44(5):732-736. PubMed ID: 33952829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro synergistic effect of colistin and ampicillin/sulbactam with several antibiotics against clinical strains of multi-drug resistant Acinetobacter baumannii.
    Shafiee F; Naji Esfahani SS; Hakamifard A; Soltani R
    Indian J Med Microbiol; 2021 Jul; 39(3):358-362. PubMed ID: 33906750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens.
    Bian X; Liu X; Hu F; Feng M; Chen Y; Bergen PJ; Li J; Li X; Guo Y; Zhang J
    Front Pharmacol; 2021; 12():785893. PubMed ID: 35058776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia.
    Cies JJ; Fugarolas KN; Moore WS; Mason RW; Menkiti OR
    Pharmacotherapy; 2017 Apr; 37(4):456-463. PubMed ID: 28226400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam.
    Sullivan MC; Nightingale CH; Quintiliani R; Sweeney KR
    Pharmacotherapy; 1995; 15(4):479-86. PubMed ID: 7479201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo efficacy and PK/PD analyses of zifanocycline (KBP-7072), an aminomethylcycline antibiotic, against Acinetobacter baumannii in a neutropenic murine thigh infection model.
    Li L; Tan X; Zhou T; Chi S; Zhu Y; Liu Q; Chen Y; Zhang J
    J Infect Chemother; 2024 Jan; 30(1):34-39. PubMed ID: 37714267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefoperazone/sulbactam therapeutic drug monitoring in patients with liver cirrhosis: Potential factors affecting the pharmacokinetic/pharmacodynamic target attainment.
    Dong Y; Li Y; Zhang Y; Zhang T; Zhu L; Dong Y; Wang T
    Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):353-359. PubMed ID: 31056857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant
    Zhang J; Diao S; Liu Y; Wang H; Liu Y; Zhu S; Feng K; Tang X; Oo C; Zhu P; Lv Z; Yu M; Sy SKB; Zhu Y
    Front Microbiol; 2022; 13():1024702. PubMed ID: 36483204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single-center retrospective observational study.
    Suzuki T; Sugiyama E; Nozawa K; Tajima M; Takahashi K; Yoshii M; Suzuki H; Sato VH; Sato H
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00746. PubMed ID: 33764686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.